Search

Your search keyword '"Verónica Escudero"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Verónica Escudero" Remove constraint Author: "Verónica Escudero"
50 results on '"Verónica Escudero"'

Search Results

3. Detección de nefrotóxicos y ajuste de dosis en pacientes con filtrado glomerular bajo realizado en farmacia comunitaria: metodología

4. Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes

5. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism

6. Lipid profile of patients treated with evolocumab in Spanish hospital nephrology units (RETOSS NEFRO)

7. Perfil clínico de los pacientes tratados con evolocumab en unidades hospitalarias de nefrología en España (RETOSS-NEFRO)

8. Graft survival differences in kidney transplants related to recipient sex and age

9. Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study.

10. Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register

12. Perfil clínico de los pacientes tratados con evolocumab en unidades hospitalarias de nefrología en España (RETOSS-NEFRO)

13. What has been driving work-to-work transitions in the emerging world? : a comparative study of Indonesia and South Africa

14. Dimension géographique des inégalités d’accès à l’emploi

18. Monitoreo microbiológico para la gestión ambiental de Aguas Residuales Hospitalarias

19. Disorders in bone-mineral parameters and the risk of death in persons with chronic kidney disease stages 4 and 5: the PECERA study

20. Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia

21. Prevalence of Vertebral Fractures and Their Prognostic Significance in the Survival in Patients with Chronic Kidney Disease Stages 3‒5 Not on Dialysis

22. La Garantie européenne pour la jeunesse

23. Effectiveness of Active Labor Market Tools in Conditional Cash Transfers Programs: Evidence for Argentina

24. FP116TRAJECTORY OF POTASSIUM MEASUREMENTS IN PATIENTS WITH ACUTE SEVERE HYPERKALEMIA AND LONG-TERM ALL-CAUSE MORTALITY

25. SP489The role of CA125 as a volume marker before and after hemodialysis session

26. The employment effect of changes in the composition of fiscal consolidations

27. Joint provision of income and employment support: Evidence from a crisis response in Uruguay

28. Improving Competitiveness and Fostering Productivity in Spain

29. Active Labour Market Programmes in Latin America and the Caribbean: Evidence from a Meta-Analysis

30. Vascular Calcification in Patients with Nondialysis CKD over 3 Years

31. Youth Labour Market Prospects and Recent Policy Developments

32. Active Labour Market Programmes in Latin America and the Caribbean: Evidence from a Meta Analysis

33. SP470RELATIONSHIP BETWEEN PREDICTIVE KT/V AND CALCULATED KT/V ACHIEVED WITH NXSTAGE CYCLER IN SHORT-DAILY HOME HEMODIALYSIS PATIENTS

34. Freud, ¿pedagogo o antipedagogo?

35. How to shift to a more equitable and job-friendly path

36. La centroizquierda en la Argentina: el Frente País Solidario (FREPASO), la Alianza y el Frente para la Victoria (FpV) -kirchnerismo

37. What is the optimal level of vitamin D in non-dialysis chronic kidney disease population?

38. Fiscal consolidation and employment growth

39. Making profits work for investment and jobs

40. Are active labour market policies effective in activating and integrating low-skilled individuals? An international comparison

41. MP369MINERAL METABOLISM OUTCOMES OF A TREATMENT PROTOCOL FOR CONTROLLING SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS. A PROSPECTIVE COHORT STUDY

42. Understanding the Drivers of the Youth Labour Market in Kenya

43. FP333WHICH FACTORS HAVE INFLUENCE ON THE MORBIDITY, INITIATION OF DIALYSIS AND MORTALITY OF PATIENTS WITH CKD STAGE 4 AND 5 NOT ON DIALYSIS? FINAL RESULTS FROM THE PECERA STUDY

44. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study

45. MP396VASCULARCALCIFICATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 4, 5 AND 5D:RECAVAS STUDY

46. Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: results of the OSERCE study

47. FP421PROGNOSTIC SIGNIFICANCE OF THE PRESENCE OF VERTEBRAL FRACTURES IN THE SURVIVAL OF CHRONIC KIDNEY DISEASE PATIENTS STAGES 3-5 NOT ON DIALYSIS

48. Renal transplantation - clinical studies - 2

50. What is the optimal level of vitamin D in non-dialysis chronic kidney disease population?

Catalog

Books, media, physical & digital resources